caffeic acid has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q; Wang, J; Wei, F; Xie, X; Yu, Y; Zhang, M | 1 |
| Abulizi, P; Ji, L; Lu, B; Mei, X; Yu, Z; Zhang, T; Zhou, L | 1 |
2 other study(ies) available for caffeic acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Integrated serum pharmacochemistry and serum pharmacology to investigate the active components and mechanism of Bushen Huoxue Prescription in the treatment of diabetic retinopathy.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Humans; Vascular Endothelial Growth Factor A | 2023 |
Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Caffeic Acids; Cell Line; Cell Proliferation; Cell Survival; Chlorogenic Acid; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Endothelial Cells; Lonicera; Luteolin; Mice, Inbred C57BL; Phytotherapy; Plant Extracts; Plants, Medicinal; Platelet Endothelial Cell Adhesion Molecule-1; Retinal Neovascularization; Retinal Vessels; Signal Transduction; Streptozocin; Time Factors; Vascular Endothelial Growth Factor A | 2016 |